CorMedix CRMD
NASDAQ CRMD
$7.76 +0.19 (+2.58%)
As of: Oct 21, 2026 · 1:39 PM EDT

CorMedix (CRMD) Convertible Debt (2012 - 2019)

Updated

CorMedix (CRMD) posted Convertible Debt of $6.73 million for Q2 2019, up 4.8% from the prior quarter.

Analysis

CorMedix (CRMD) Convertible Debt (2012 - 2019) Analysis & Trends

At the end of FY2018, CorMedix's Convertible Debt came in at $6.13 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.17 Bn 1,102.76 Bn 19.71 Bn
2 Johnson & Johnson 615.84 Bn 534.36 Bn 17.26 Bn
3 AbbVie 500.69 Bn 473.80 Bn 12.70 Bn
4 Merck 367.34 Bn 321.72 Bn 12.21 Bn
5 Novartis Ag 297.61 Bn 261.60 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.75 Bn 12.86 Bn
7 Amgen 235.51 Bn 190.91 Bn 7.24 Bn
8 Gilead Sciences 190.60 Bn 164.80 Bn 6.22 Bn
9 Pfizer 169.37 Bn 116.02 Bn 10.94 Bn
10 CorMedix 610.69 Mn -41.83 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 6.73 Mn
Mar 31, 2019 6.43 Mn
Dec 31, 2018 6.13 Mn
Mar 31, 2013 207,467.00
Dec 31, 2012 16,061.00
Sep 30, 2012 42,540.00
API Access

CorMedix Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=CRMD&period=max&api_key=YOUR_API_KEY